| Name | Title | Contact Details |
|---|---|---|
Andy Denison |
Chief Technology Officer | Profile |
BLUEBONNET® Abstract and Title is a locally owned and operated title company located in Brenham and Bellville Texas and serving adjacent counties. We are fully licensed in Washington, Austin, Fayette, Brazos, Grimes, Robertson, Colorado, and Lee Counties, and serve the adjoining counties (such as Waller), regularly. BLUEBONNET® was established to provide a title company focused on the customer and the community. BLUEBONNET® sets itself apart from its competitors by providing excellent customer service in all aspects of the real estate transaction. Our customers actually enjoy the real estate closing process – we know you will too.
Founded in 1904, the Fédération Internationale de Football Association (FIFA) is the umbrella organisation of its members, currently 211 national football associations. Its main objectives, enshrined in its statutes, are to develop football around the world, to stage international competitions and to protect the integrity of football (against match manipulation, doping etc.). FIFA is composed of a number of political bodies (such as the FIFA Congress and the FIFA Council) and the administration. The highest political position is the FIFA President, elected every four years by FIFAs member associations. The FIFA administration, with more than 800 people from over 60 nations, is based in Zurich. It is run by the Secretary General (CEO). FIFA stages FIFA World Cups™ in various forms such as youth, mens and womens, futsal, beach soccer or club competitions. The mens FIFA World Cup™ is not only the most popular single sporting event in the world but also the financial backbone for FIFA and its efforts to develop football worldwide. The financial success of the FIFA World Cup™ allows FIFA to run a wide range of football development programmes and to provide funds, infrastructure and know-how to its member associations through the FIFA Forward Development Programme. For more information visit our website.
From the food you eat to the fuels you require, CPM plays an important role in building a more efficient and sustainable world. Our experienced team and family of trusted brands are working together to make our planet a better place to live. Feed Solutions: Were innovating nutrition for both people and animals. Our processes and equipment extract oils and plant-based proteins and create ground and pelleted feed for livestock. Fuel Solutions: Our extensive experience in processing agricultural material has made us a leader in renewable fuel production. We help our customers create renewable diesel, ethanol, sustainable aviation fuel, biogas and energy storage technologies, and our machines create wood pellets, firelogs and briquettes that provide sustainable, renewable cleaner-burning fuels. Build Solutions: From the extrusion machines that help create parts for mobility markets to processes that solve complex recycling challenges to equipment that promotes the use of sustainable aluminum packaging, we contribute the materials and processes to build a better world.
Goodturn is a family of brands that provide automotive and tire repair and maintenance services. We partner with leading brands who are looking to accelerate their growth while offering greater opportunities for their employees to reach their fullest potential. Our company is built around delivering outstanding customer service and building winning cultures.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.